Cargando…

Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging

The antifungal drug posaconazole has shown significant activity against Trypanosoma cruzi in vitro and in experimental murine models. Despite this, in a recent clinical trial it displayed limited curative potential. Drug testing is problematic in experimental Chagas disease because of difficulties i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Francisco, Amanda Fortes, Lewis, Michael D., Jayawardhana, Shiromani, Taylor, Martin C., Chatelain, Eric, Kelly, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2015
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505219/ https://www.ncbi.nlm.nih.gov/pubmed/26014936 http://dx.doi.org/10.1128/AAC.00520-15

Ejemplares similares

Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathy
por: Lewis, Michael D., et al.
Publicado: (2016)

Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage
por: Francisco, Amanda Fortes, et al.
Publicado: (2016)

Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure
por: Francisco, Amanda Fortes, et al.
Publicado: (2022)

Assessing the Effectiveness of Curative Benznidazole Treatment in Preventing Chronic Cardiac Pathology in Experimental Models of Chagas Disease
por: Francisco, Amanda Fortes, et al.
Publicado: (2018)

In Vivo Analysis of Trypanosoma cruzi Persistence Foci at Single-Cell Resolution
por: Ward, Alexander I., et al.
Publicado: (2020)

Intracellular DNA replication and differentiation of Trypanosoma cruzi is asynchronous within individual host cells in vivo at all stages of infection
por: Taylor, Martin C., et al.
Publicado: (2020)

Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection
por: Mann, Gurdip Singh, et al.
Publicado: (2020)

Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
por: Jayawardhana, Shiromani, et al.
Publicado: (2023)

Expanding the toolbox for Trypanosoma cruzi: A parasite line incorporating a bioluminescence-fluorescence dual reporter and streamlined CRISPR/Cas9 functionality for rapid in vivo localisation and phenotyping
por: Costa, Fernanda Cristina, et al.
Publicado: (2018)

Combination With Tomatidine Improves the Potency of Posaconazole Against Trypanosoma cruzi
por: Rocha-Hasler, Marianne, et al.
Publicado: (2021)

A New Experimental Model for Assessing Drug Efficacy against Trypanosoma cruzi Infection Based on Highly Sensitive In Vivo Imaging
por: Lewis, Michael D., et al.
Publicado: (2015)

Synergic Effect of Allopurinol in Combination with Nitroheterocyclic Compounds against Trypanosoma cruzi
por: Mazzeti, Ana Lia, et al.
Publicado: (2019)

Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
por: Chen, Chiung-Kuang, et al.
Publicado: (2010)

Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice
por: Diniz, Lívia de Figueiredo, et al.
Publicado: (2018)

The Trypanosoma cruzi Vitamin C Dependent Peroxidase Confers Protection against Oxidative Stress but Is Not a Determinant of Virulence
por: Taylor, Martin C., et al.
Publicado: (2015)

Long term follow-up of Trypanosoma cruzi infection and Chagas disease manifestations in mice treated with benznidazole or posaconazole
por: Calvet, Claudia Magalhães, et al.
Publicado: (2020)

Sensibilidad in vitro a benznidazol, nifurtimox y posaconazol de cepas de Trypanosoma cruzi de Paraguay
por: Acosta, Nidia, et al.
Publicado: (2020)

Clinical Outcomes of Oral Suspension versus Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections
por: Furuno, Jon P., et al.
Publicado: (2018)

Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection
por: Engel, Juan C., et al.
Publicado: (1998)

Brazilian Green Propolis: Effects In Vitro and In Vivo on Trypanosoma cruzi
por: Salomão, Kelly, et al.
Publicado: (2011)

Image-Based In Vitro Screening Reveals the Trypanostatic Activity of Hydroxymethylnitrofurazone against Trypanosoma cruzi
por: Scarim, Cauê Benito, et al.
Publicado: (2021)

Biological factors that impinge on Chagas disease drug development
por: FRANCISCO, AMANDA F., et al.
Publicado: (2017)

Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection
por: Lewis, Michael D, et al.
Publicado: (2014)

Cardiac Abnormalities in a Predictive Mouse Model of Chagas Disease
por: Francisco, Amanda Fortes, et al.
Publicado: (2023)

Incomplete Recruitment of Protective T Cells Is Associated with Trypanosoma cruzi Persistence in the Mouse Colon
por: Ward, Alexander I., et al.
Publicado: (2022)

Imaging the development of chronic Chagas disease after oral transmission
por: Lewis, Michael D., et al.
Publicado: (2018)

In cellulo and in vivo assays for compound testing against Trypanosoma cruzi
por: Guerra-Slompo, Eloise Pavão, et al.
Publicado: (2023)

Development of an Aptamer-Based Concentration Method for the Detection of Trypanosoma cruzi in Blood
por: Nagarkatti, Rana, et al.
Publicado: (2012)

Repetitive DNA is associated with centromeric domains in Trypanosoma brucei but not Trypanosoma cruzi
por: Obado, Samson O, et al.
Publicado: (2007)

Profiling the Trypanosoma cruzi Phosphoproteome
por: Marchini, Fabricio K., et al.
Publicado: (2011)

Clathrin expression in Trypanosoma cruzi
por: Kalb, Ligia Cristina, et al.
Publicado: (2014)

Endothelial Transmigration by Trypanosoma cruzi
por: Coates, Bria M., et al.
Publicado: (2013)

The N-myristoylome of Trypanosoma cruzi
por: Roberts, Adam J., et al.
Publicado: (2016)

Screening of Potential anti-Trypanosoma cruzi Candidates: In Vitro and In Vivo Studies
por: Soeiro, Maria de Nazaré C, et al.
Publicado: (2011)

Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In Vivo
por: Batista, Denise da Gama Jaén, et al.
Publicado: (2011)

Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi
por: Brand, Stephen, et al.
Publicado: (2017)

Synthesis and Anti-Trypanosoma cruzi Activity of Diaryldiazepines
por: Menezes, Júlio César L., et al.
Publicado: (2014)

Reaching for the Holy Grail: insights from infection/cure models on the prospects for vaccines for Trypanosoma cruzi infection
por: Bustamante, Juan, et al.
Publicado: (2015)

Challenges in Chagas Disease Drug Development
por: Francisco, Amanda F., et al.
Publicado: (2020)

Recent, Independent and Anthropogenic Origins of Trypanosoma cruzi Hybrids
por: Lewis, Michael D., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4vkfm471o804kr780ib4dcnhjq